Type 1 cryoglobulinemia: Response to thalidomide and lenalidomide

Journal of Clinical Rheumatology

Volumn 17, Issue 3, 2011, Pages 145-147

  Calabrese, Cassandra ^a   Faiman, Beth ^b   Martin, David ^c   Reu, Frederic ^b   Calabrese, Leonard H ^b,d  

^a OHIO UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^d CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; GLUCOCORTICOID; LENALIDOMIDE; PREDNISONE; RITUXIMAB; THALIDOMIDE;

ADULT; APHERESIS; ARTICLE; CASE REPORT; CONNECTIVE TISSUE DISEASE; CRYOGLOBULINEMIA; DRUG DOSE REDUCTION; DRUG MEGADOSE; HUMAN; INFECTION; MALE; NEUROPATHY; PRIORITY JOURNAL; PURPURIC RASH; SKIN ULCER; SMALL VESSEL VASCULITIS; TREATMENT OUTCOME; TREATMENT RESPONSE;

CRYOGLOBULINEMIA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; THALIDOMIDE; TREATMENT OUTCOME;

EID: 79955071798     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3182155e8d     Document Type: Article

References (20)

1. Nehme-Schuster H, Korganow A-S, Pasquali J-L, et al. Rituximab inefficiency during type I cryoglobulinaemia. Rheumatology. 2005;44:410-411.
2. Cem Ar M, Soysal T, Hatemi G, et al. Successful management of cryoglobulinemia-induced leukocytoclastic vasculitis with thalidomide in a patient with multiple myeloma. Ann Hematol. 2005;84:609-613. (Pubitemid 41194550)
3. Sampson A, Callen JP. Thalidomide for type 1 cryoglobulinemic vasculopathy. Arch Dermatol. 2006;142:972-974. (Pubitemid 44268472)
4. Shah SR, Tran TM. Lenalidomide in myelodysplastic syndrome and multiple myeloma. Drugs. 2007;67:1869-1881. (Pubitemid 47347398)
5. Kyle RA, Treon SP, Alexanian R, et al. Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol. 2003;30:116-120. (Pubitemid 36506292)
6. Dimopoulos M, Merlini G, Leblond V, et al. How we treat Waldenstrom's macroglobulinemia. Haematologica. 2005;90:117-125.
7. Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia. 2009;23:3-9.
8. IMW Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the international myeloma working group. Br J Haematol. 2003;121: 749-757.
9. Knight R. IMiDs: a novel class of immunomodulators. Semin Oncol. 2005;32:24-30.
10. WAF-1 expression in both lymphoma and multiple myeloma through a LSD1-mediated epigenetic mechanism. Cancer Res. 2009;69:7347-7356.
11. + cells. J Clin Investig. 2008;118:248-258.
12. Quach H, Ritchie D, Stewart AK, et al. Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma. Leukemia. 2009;24:22-32.
13. Rossi D, De Paoli L, Franceschetti S, et al. Prevalence and clinical characteristics of immune thrombocytopenic purpura in a cohort of monoclonal gammopathy of uncertain significance. Br J Haematol. 2007;138:249-252. (Pubitemid 46976319)
14. Lin RJ, Curran JJ, Zimmerman TM, et al. Lenalidomide for the treatment of cryoglobulinemia and undifferentiated spondyloarthropathy in a patient with multiple myeloma. J Clin Rheumatol. 2010;16:90-91.
15. Kyle RA, Rajkumar SV. Multiple myeloma. Blood. 2008;111: 2962-2972.
16. Hillengass J, Ho A, Goldschmidt H, et al. Clinical evidence for immunomodulation induced by high-dose melphalan and autologous blood stem cell transplantation as cause for complete clinical remission of multiple myeloma-associated cryoglobulin-vasculitis. Int J Hematol. 2008;88:454-456.
17. Green J, Upjohn E, McCormack C, et al. Successful treatment of Beh0et's disease with lenalidomide. Br J Dermatol. 2008;158:197-198. (Pubitemid 350221917)
18. Dispenzieri A, Klein CJ, Mauermann ML. Lenalidomide therapy in a patient with POEMS syndrome. Blood. 2007;110:1075-1076. (Pubitemid 47267453)
19. Sethi S, Tageja N, Arabi H, et al. Lenalidomide therapy in a rare case of POEMS syndrome with kappa restriction. South Med J. 2009;102:1092-1093.
20. Jaccard A, Abraham J, Recher C, et al. Lenalidomide therapy in nine patients with POEMS syndrome. Blood. 2009. [Abstract 3872].